Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
| Autor: | P. De Vuyst, P. A. Gevenois, M. Mairesse, Christine Lenclud, Christiane Knoop |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Pulmonary and Respiratory Medicine
Pathology medicine.medical_specialty Pleural effusion business.industry Pneumoconiosis Respiratory disease Asbestosis Occupational disease respiratory system medicine.disease medicine.disease_cause Asbestos respiratory tract diseases Pleural disease medicine Differential diagnosis business |
| Zdroj: | European Respiratory Journal. 10:2898-2901 |
| ISSN: | 1399-3003 0903-1936 |
| DOI: | 10.1183/09031936.97.10122898 |
| Popis: | Two patients with pleural plaques developed pleural effusion and subsequent diffuse pleural fibrosis 50 and 39 yrs after their first exposure to asbestos. The diagnosis of benign asbestos pleural effusion was suggested, but the work-up finally suggested bromocriptine-induced pleural disease in both patients. These two cases illustrate that drug-induced pleural effusion is an important differential diagnosis of benign asbestos pleural effusion. It is, moreover, possible that pre-existing asbestos pleural lesions, or even asbestos exposure, increases the risk of developing bromocriptine-induced pleural disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|